Minoxidil

Minoxidil is used in the management of hypertension, acting on vascular smooth muscle to reduce systemic resistance.

• Severe resistant hypertension: lowers blood pressure when other antihypertensive agents have failed.
• Refractory hypertension: used as an adjunct to existing therapy to achieve target pressures.
• Hypertensive crisis (inpatient setting): may be administered under specialist supervision for rapid blood‑pressure control.

• Minoxidil activates ATP‑sensitive potassium channels in vascular smooth‑muscle cells, causing membrane hyperpolarisation. This leads to relaxation of the smooth muscle, vasodilation, and a consequent reduction in systemic vascular resistance and arterial blood pressure.

Minoxidil may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects

• Fluid retention: peripheral edema, weight gain.
• Tachycardia: increased heart rate, palpitations.
• Hypertrichosis: excessive hair growth on face and body.
• Headache: mild to moderate intensity.
• Dizziness: especially on standing.
• Nausea: occasional gastrointestinal upset.

Serious or Rare Side Effects

• Pericardial effusion: accumulation of fluid around the heart.
• Myocardial ischemia: chest pain due to reduced coronary blood flow.
• Severe hypotension: dangerously low blood pressure.
• Stevens‑Johnson syndrome: severe skin reaction.
• Hepatotoxicity: abnormal liver function tests.
• Anaphylaxis: rare systemic allergic reaction.

Before initiating therapy, clinicians should evaluate cardiovascular status and monitor for fluid overload.

• Baseline assessment: obtain blood pressure, heart rate, and cardiac function tests.
• Concomitant diuretics: consider to mitigate edema, but monitor electrolytes.
• Beta‑blockers: may be required to control reflex tachycardia.
• Pregnancy: use only if potential benefit justifies risk, as safety data are limited.
• Breastfeeding: avoid unless benefits outweigh potential infant exposure.
• Store at ambient temperature: keep below 25 °C, retain in original container, protect from moisture and direct sunlight.

Minoxidil can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Non‑selective beta‑blockers: may exacerbate tachycardia and reduce antihypertensive effect.
• Central alpha‑agonists (e.g., clonidine): can cause severe hypertension rebound if discontinued abruptly.
• MAO inhibitors: potential for unpredictable blood‑pressure changes.

Moderate Interactions (Monitor Closely)

• Loop or thiazide diuretics: increase risk of electrolyte imbalance and dehydration.
• ACE inhibitors or ARBs: additive blood‑pressure lowering effect, monitor for hypotension.
• Calcium channel blockers: may enhance vasodilatory response, requiring dose adjustments.